Wird geladen...

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol

INTRODUCTION: Sodium-glucose co-transporter-2 (SGLT2) inhibitors are oral antihyperglycemic agents for the treatment of people with type 2 diabetes (T2DM). Two recent cardiovascular outcome trials (CVOTs), the EMPA-REG OUTCOME trial and CANVAS Program, have demonstrated that SGLT2 inhibitors have ca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Ther
Hauptverfasser: Hinton, William, Feher, Michael D., Munro, Neil, de Lusignan, Simon
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Healthcare 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531500/
https://ncbi.nlm.nih.gov/pubmed/31041781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-0620-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!